药房公司为新西兰所有儿童提供囊性纤维化治疗. Pharmac to fund cystic fibrosis drugs for all children in New Zealand.

新西兰的药学公司周三宣布,将为所有儿童提供Trikafta和Alyftrek囊性纤维化治疗药物资金,不论年龄如何,结束了以前限制6岁及以上儿童使用. Pharmac in New Zealand announced Wednesday that it will fund cystic fibrosis medications Trikafta and Alyftrek for all children, regardless of age, ending previous restrictions that limited access to those six and older. 这一变化使医生可以根据临床需要而不是年龄来开药, 消除了家庭的经济障碍, 并旨在改善长期健康结果. This change allows doctors to prescribe the drugs based on clinical need rather than age, removing financial barriers for families and aiming to improve long-term health outcomes.